Africa Footprint
Our Africa Footprint
Country teams on the ground across Anglophone, Francophone, East and Southern Africa.
Population
1.3 billion
An expanding middle class with 60% of the population under 25.
Pharma Market
$45B+
Sub-Saharan Africa's pharmaceutical market continues to expand year-on-year.
Countries
57
Across the continent — 20 within our active operational footprint.
Complexity
Multi-jurisdiction
International, national, corporate, customary and common law systems coexist.
Our Sub-Saharan Footprint
Four regions, one operating standard.
Anglophone West Africa
GhanaNigeriaSierra LeoneLiberia
Group Headquarters (Accra) and Nigeria operations (Lagos).
Francophone Africa
Côte d'IvoireSenegalCameroonGabonMauritaniaMali
Extended through our Joint Venture with Groupe ETHICA — PharmaSymbiosis.
East Africa
KenyaTanzaniaUgandaEthiopiaSudan
Country teams in Nairobi and Kampala servicing the EAC.
Southern Africa (SADC)
BotswanaNamibiaMauritiusZambia
Country office in Gaborone, Botswana.
Heritage
74 years of presence in Africa.
Through our Joint Venture PharmaSymbiosis with Groupe ETHICA, our combined heritage spans seven decades of pharmaceutical commercialization and patient access work across the continent.